D’Amico and colleagues demonstrated that deleting Rac1 specifically from tumour ECs did not alter tumour growth and angiogenesis in wild-type mice but significantly decreased tumour vascular formation and inhibited tumour development in mice lacking integrin β3 expression [48], indicating a context-dependent role of Rac1 in tumour ECs. This evidence concerns the gene RAC1 and neoplasm.